Skip to main content

New story in Health from Time: A Low-Cost Steroid Shows Promise for Treating COVID-19. But Take the News with a Grain of Salt



Encouraging results from researchers looking into potential COVID-19 treatments are being hailed as a “groundbreaking development”—but recent history shows it’s worth taking these promising findings with a grain of salt.

Investigators working on the U.K.-based RECOVERY trial announced today that dexamethasone, a low-cost and widely available steroid that lowers inflammation, improved patients’ chances of surviving severe COVID-19. During the study, about 2,100 COVID-19 patients were treated with dexamethasone for 10 days. Patients on mechanical ventilation who were given dexamethasone were 35% less likely to die compared to patients on ventilators who did not get the treatment. In patients on less invasive forms of breathing support, dexamethasone decreased the risk of death by 20%, while patients who did not require any respiratory help saw no improvements after taking the steroid.

Those are promising findings, and it makes sense that an anti-inflammatory drug would be effective against a disease that’s most harmful when it spurs excess inflammation in the body. But there’s a big caveat: the researchers released only a summary of the data, rather than a complete, peer-reviewed paper. (The researchers said in a statement they’ll publish their full findings soon.)

It’s understandable that these researchers would want to get the news out as soon as possible, given the possibility that dexamethasone could, based on the results, save lives immediately. But some health experts are warning the public to interpret the results with caution—especially in light of a recent scandal in which two prominent medical journals, the Lancet and the New England Journal of Medicine, had to retract high-profile studies on potential COVID-19 treatments due to suspect data.

“It will be great news if dexamethasone, a cheap steroid, really does cut deaths by 1/3 in ventilated patients with COVID-19, but after all the retractions and walk backs, it is unacceptable to tout study results by press release without releasing the paper,” influential surgeon and author Dr. Atul Gawande wrote on Twitter this morning.

The anti-malarial drug hydroxychloroquine serves as a cautionary tale. A small French study from March sparked a flurry of excitement (and glowing praise from President Donald Trump) over hydroxychloroquine’s potential to treat COVID-19. But as more robust studies came out, findings began to suggest the drug is at best ineffective, and at worst potentially harmful. Eventually, the growing body of research led the U.S. Food and Drug Administration to revoke the drug’s emergency use authorization.

The hope, of course, is that no such thing happens with dexamethasone. If the drug truly works as well as the early results suggest, it could revolutionize the way severe COVID-19 is treated. But the rapidly evolving COVID-19 pandemic, which has spurred scientists to produce a staggering amount of work in record time, has also exposed the drawbacks of accelerating past the traditionally slow-and-steady scientific review process. Mistakes happen, and conclusions change—especially when the whole world is impatient for answers.

Popular posts from this blog

New story in Health from Time: 3 More People Diagnosed With Coronavirus in Northern California

Three more people in Northern California have been diagnosed with the coronavirus known as 2019-nCoV, health officials in the area said Sunday, doubling the number of cases in the state and bringing the total across the country to 11 . The patients, whose symptoms are not yet serious enough to warrant hospitalization, are being kept in their homes, where they are being closely monitored, the San Francisco Chronicle reports . Two of the patients are a husband and wife from San Benito County. The husband fell ill after he returned home from Wuhan, China, where the outbreak began. It is believed he transferred the virus to his wife, who had not been to China. The other patient became sick while visiting family in Santa Clara County. She also previously visited Wuhan. Since arriving in the United States on Jan. 23, she has only left her home twice to seek out medical assistance. Officials from both counties said they are working to identify anyone who may have come into cont...

New video by blogilates on YouTube

Day 8 - 14 | Blogilates 2020 Challenge You guys are CRUSHING the #2020Challenge so far! Idk about you but my abs are soooooore! This week, we're doing 20 reps of abs every day + 20 reps of another new exercise every day! If you need a little extra motivation, text my number (510-692-4556) and tell me all about it so we can come up with a solution together! This link also works: https://ift.tt/2Qjqw7G This week's moves are: Jan. 8th (starts 0:48) - 20 butterfly bridges + 20 criss cross (butt + abs) Jan. 9th (starts 2:43) - 20 oil riggers + 20 rollovers (arms + abs) Jan. 10th (starts 8:29) - 20 lunges + 20 leg outs (legs + abs) Jan. 11th (starts 11:03) - 20 walnut crushers + 20 single leg drops (back + abs) Jan. 12th (starts 13:41) - 20 sprinters + 20 crunches (obliques + abs) Jan. 13th (starts 16:27) - 20 squat jumps + 20 russian twists (cardio + abs) Jan. 14th (starts 18:57) - 20 plank jacks + 20 butt ups (total body + abs) Here is where I get all of my music! Epidemic Sound: ...

New story in Health from Time: Coronavirus Cases Outside China Are Accelerating Rapidly. Here’s What to Know

A surge in deadly coronavirus cases outside China is raising concerns that the outbreak has reached a new stage and could continue its global spread to even more vulnerable countries. In the central Chinese province of Hubei, where the virus is believed to have originated, the number of cases appears to be stabilizing, according to government figures. But the number of people infected elsewhere in the world is rising quickly, with clusters in South Korea , Italy, Iran and a cruise ship docked in Japan. As of Monday, more than 2,200 cases of the virus, officially called COVID-19, have been reported outside of mainland China, where the overwhelming majority of the 79,000 cases have been located since officials first discovered the disease in December. The number of deaths outside China has also increased to 166, including 50 in Iran and four in Italy. In a news conference Monday, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus said the WHO...